Our innovative remedies are manufactured and produced by a global team of almost 14,000 employees at 16 production facilities in 11 countries. In total, there are 21 units spread over the sites: 12 pharmaceutical, 5 chemical, 4 biopharmaceutical and 1 medical. The biopharmaceutical production arm of Boehringer Ingelheim, which is based in Germany, Austria, America und China, is a global contract manufacturer for industrial customers.
The Manufacturing Division produces our medicines, making sure that they’re safe and of the highest quality. Our innovative treatments are manufactured by a global team of almost 14,000 employees at 16 production facilities in 11 countries. In total we have 21 units spread over these sites: 12 pharmaceutical, 5 chemical, 4 biopharmaceutical and 1 medical. We are a leading biopharmaceutical contract manufacturer and preferred partner for our customers. Boehringer Ingelheim BioXcellence™
The Manufacturing & Production Division produces our products for the global market – not only our bestsellers but our new and innovative products too. They make sure that our strategic products are available when patients need them. Thanks to highly qualified and motivated employees and stable processes, it’s a job they do with great success.
The Environmental Health & Safety Division focuses on occupational safety and environmental protection, including waste and residue management and disposal, in line with legal requirements. Given the nature of the waste products in chemical and pharmaceutical production, this is a critical responsibility.
The Validation Division makes sure that our equipment and technical facilities are up to the job and documents their compliance with established development requirements. Well trained staff, precise process descriptions and certified technical facilities are key. In the pharmaceutical industry, qualification and validation are essential to ensure compliance with ‘Good Manufacturing Practice’ guidelines.